Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Spinal, Epidural, and Dural Puncture Epidural Anesthesia on Maternal Hemodynamics and Block Efficacy in Cesarean Delivery: A Prospective Randomized Controlled Trial

NCT07883733 is registered in ClinicalTrials.gov with Bursa Yuksek Ihtisas Training and Research Hospital as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07883733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Spinal, Epidural, and Dural Puncture Epidural Anesthesia on Maternal Hemodynamics and Block Efficacy in Cesarean Delivery: A Prospective Randomized Controlled Trial
Lead sponsor
Bursa Yuksek Ihtisas Training and Research Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
October 1, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, obstetrical, cesarean section, hypotension after neuraxial anesthesia, post-dural puncture headache

Arms

As registered; 3 arms.

  • Spinal Anesthesia Active comparatorSpinal Anesthesia

    Participants will receive spinal anesthesia with intrathecal 10 mg of 0.5% hyperbaric bupivacaine plus 10 mcg fentanyl.

  • Epidural Anesthesia Active comparatorEpidural Anesthesia

    Participants will receive epidural anesthesia. After epidural catheter placement and a test dose, 15-20 mL of local anesthetic solution (10 mL 0.5% isobaric bupivacaine + 50 mcg fentanyl + 5 mL 2% lidocaine + 4 mL normal saline) will be administered. If bilateral T6 sensory block is not achieved within 10 minutes, 5 mL of 0.25% bupivacaine will be given every 5 minutes up to a cumulative maximum of 30 mL.

  • Dural Puncture Epidural Anesthesia Active comparatorDural Puncture Epidural Anesthesia

    Participants will receive dural puncture epidural anesthesia. The dura will be punctured with a 27G spinal needle without intrathecal drug injection, followed by epidural catheter placement, a test dose, and the same epidural regimen as the Epidural Anesthesia arm (15-20 mL of 10 mL 0.5% isobaric bupivacaine + 50 mcg fentanyl + 5 mL 2% lidocaine + 4 mL normal saline; additional 5 mL of 0.25% bupivacaine every 5 minutes up to 30 mL if bilateral T6 block is not achieved within 10 minutes).

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Incidence of Maternal Hypotension From completion of the neuraxial block (time 0) until the end of surgery (approximately 90 minutes)

    Proportion of participants who develop at least one episode of hypotension, defined as a decrease in mean arterial pressure of more than 20% from baseline or systolic blood pressure below 90 mmHg. Baseline values are recorded before the neuraxial block. Blood pressure will be measured non-invasively every 3 minutes for the first 20 minutes after completion of the block and every 5 minutes thereafter until the end of surgery.

Lead sponsor's other trials

Bursa Yuksek Ihtisas Training and Research Hospital, most recent start first.

Similar trials

Same condition (Post-Dural Puncture Headache) and phase, most recent start first.